作者: Kenneth J. Craddock , Shirley Tam , Chang-Qi Zhu , Ming-Sound Tsao
DOI: 10.1007/978-94-007-5842-1_1
关键词:
摘要: Genome-wide studies of lung cancer began with RNA expression microarrays, followed by DNA copy number microarrays. More recently, microRNA profiling and high-throughput sequencing have entered the arena. Cancer genomics is a quickly moving field. Here, we summarize pertinent findings to date, an emphasis on diagnostic, prognostic, predictive that been validated or confirmed multiple studies.